114 related articles for article (PubMed ID: 9565372)
1. LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal.
Le Guiner S; Le Dréan E; Labarrière N; Fonteneau JF; Viret C; Diez E; Jotereau F
Eur J Immunol; 1998 Apr; 28(4):1322-31. PubMed ID: 9565372
[TBL] [Abstract][Full Text] [Related]
2. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
[TBL] [Abstract][Full Text] [Related]
3. ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis.
Braakman E; Goedegebuure PS; Vreugdenhil RJ; Segal DM; Shaw S; Bolhuis RL
Int J Cancer; 1990 Sep; 46(3):475-80. PubMed ID: 1975566
[TBL] [Abstract][Full Text] [Related]
4. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
[TBL] [Abstract][Full Text] [Related]
5. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
6. Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles.
Maccalli C; Mortarini R; Parmiani G; Anichini A
Int J Cancer; 1994 Apr; 57(1):56-62. PubMed ID: 7908659
[TBL] [Abstract][Full Text] [Related]
7. T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis.
Anichini A; Mortarini R; Alberti S; Mantovani A; Parmiani G
Int J Cancer; 1993 Apr; 53(6):994-1001. PubMed ID: 8097188
[TBL] [Abstract][Full Text] [Related]
8. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjögren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 1995; 15(3-4):235-53. PubMed ID: 8834450
[TBL] [Abstract][Full Text] [Related]
9. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions.
Gervois N; Guilloux Y; Diez E; Jotereau F
J Exp Med; 1996 May; 183(5):2403-7. PubMed ID: 8642353
[TBL] [Abstract][Full Text] [Related]
10. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
Guilloux Y; Viret C; Gervois N; Le Dréan E; Pandolfino MC; Diez E; Jotereau F
Eur J Immunol; 1994 Sep; 24(9):1966-73. PubMed ID: 7522155
[TBL] [Abstract][Full Text] [Related]
11. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
12. Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles.
Parra E; Wingren AG; Hedlund G; Björklund M; Sjögren HO; Kalland T; Sansom D; Dohlsten M
J Immunol; 1994 Sep; 153(6):2479-87. PubMed ID: 7521363
[TBL] [Abstract][Full Text] [Related]
13. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
Shier P; Ngo K; Fung-Leung WP
J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
[TBL] [Abstract][Full Text] [Related]
14. Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes.
Anikeeva N; Somersalo K; Sims TN; Thomas VK; Dustin ML; Sykulev Y
Proc Natl Acad Sci U S A; 2005 May; 102(18):6437-42. PubMed ID: 15851656
[TBL] [Abstract][Full Text] [Related]
15. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
16. T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro.
Viret C; Gervois N; Guilloux Y; Le Dréan E; Diez E; Jotereau F
Int Immunol; 1995 Oct; 7(10):1535-43. PubMed ID: 8562498
[TBL] [Abstract][Full Text] [Related]
17. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro.
Böhmig GA; Kovarik J; Holter W; Pohanka E; Zlabinger GJ
J Immunol; 1994 Apr; 152(8):3720-8. PubMed ID: 7511657
[TBL] [Abstract][Full Text] [Related]
18. T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production.
Willemsen RA; Ronteltap C; Chames P; Debets R; Bolhuis RL
J Immunol; 2005 Jun; 174(12):7853-8. PubMed ID: 15944290
[TBL] [Abstract][Full Text] [Related]
19. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.
Viret C; Davodeau F; Guilloux Y; Bignon JD; Semana G; Breathnach R; Jotereau F
Eur J Immunol; 1993 Jan; 23(1):141-6. PubMed ID: 8419164
[TBL] [Abstract][Full Text] [Related]
20. Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling.
Wingren AG; Dahlenborg K; Björklund M; Hedlund G; Kalland T; Sjögren HO; Ljungdahl A; Olsson T; Ekre HP; Sansom D
J Immunol; 1993 Aug; 151(3):1328-36. PubMed ID: 7687629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
